AstraZeneca PLC is 207.4x more valuable than ATAI Life Sciences N.V. by market capitalization ($286.27 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | AZN |
|---|---|---|
| Market cap | $1.38 B | $286.27 B |
| US-listed rank | #2408 | #47 |
| Revenue (latest FY) | $308.00K | - |
| Net income (latest FY) | -$149.27M | - |
| Net margin | -48464.0% | - |
| SEC filings | 320 | 1,004 |
AstraZeneca PLC is 207.4x more valuable than ATAI Life Sciences N.V. by market capitalization ($286.27 B vs $1.38 B).
Full pages: ATAI Life Sciences N.V. and AstraZeneca PLC, or browse the full rankings.